medigraphic.com
Revista Médica Sinergia

2021, Number 06

<< Back Next >>

Revista Médica Sinergia 2021; 6 (06)

Clostridium difficile infection and the role of the fecal microbiota transplant

Chacón SMA, Bermúdez DLV, Rojas SDM

Language: Spanish
References: 16
Page: 1-10
PDF size: 173.48 Kb.


ABSTRACT

Clostridium difficile is an anaerobic, gram-positive bacterium capable of colonizing the colon and producing acute diarrhea. It is one of the most important nosocomial infections that causes high morbidity at the hospital level. The clinical manifestations are extensive ranging from asymptomatic carriers to fulminant colitis, with acute diarrhea being the main manifestation. Diagnosis is always suspected in any patient with acute diarrhea and risk factors; and is confirmed with a stool test capable of detecting toxins or the Clostridium difficile gene. Treatment will depend on the severity of the infection, usually using broad-spectrum antibiotics sensitive to the bacteria such as metronidazole, vancomycin or fidaxomicin. Sometimes surgery is indicated, although it is not the most common. For patients with multiple recurrences, treatment with the highest evidence of a cure rate is fecal microbiota transplantation. Prevention with isolation and hand washing measures is of paramount importance to prevent transmission between patients at the hospital level.


REFERENCES

  1. Lamont J, Kelly C, Bakken J. Clostridioides (formerly Clostridium) difficile infection in adults: Epidemiology, microbiology, and pathophysiology. Uptodate. Wolters Kluwer [internet]. 4 agosto 2020 [citado 10 marzo 2021]; [aprox. 28 p.]. Disponible en: https://www.uptodate.com/contents/clostridioides-formerly-clostridium-difficile-infection-in-adults-epidemiology-microbiology-and-pathophysiology

  2. Loo V, Davis I, Embil J, Evans G, Hota S, Lee S et al. Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines for Clostridium difficile infection. Official J AssocMed Microbiol Infect Dis Canada. [internet]. 2018 [citado 10 de marzo 2021]; 3(2): 71-92. https://doi.org/10.3138/jammi.2018.02.13

  3. McDonald LC, Gerding D, Johnson S, Bakken J, Carrol K, Coffin S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018; 66(7): e1-e48. https://doi.org/10.1093/cid/cix1085

  4. Kelly C, Lamont J. Antibiotic associated diarrhea and Clostridium difficile infection. En: Mark Feldman, Lawrence S. Friedman, Lawrence J. Brandt. Sleisenger and Fordtran. Gastrointestinal and liver disease. 10th ed. Philadelphia: Elsevier; 2016. p 1939-1954

  5. Davidovics Z, Michail S, Nicholson M, Kociolek L, Pai N, Hansen R, et al. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. [internet]. 2019 [citado 10 marzo 2021]; 68(1): 130-143 https://doi.org/10.1097/MPG.0000000000002205

  6. Lamont J, Kelly C, Bakken J. Clostridioides (formerly Clostridium) difficile infection in adults: Clinical manifestations and diagnosis. Uptodate. Wolters Kluwer [internet]. 9 diciembre 2020 [citado 10 marzo 2021]; [aprox. 33 p.]. Disponible en: https://www.uptodate.com/contents/clostridioides-formerly-clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis

  7. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015; 313(4):398-408. doi: 10.1001/jama.2014.17103. PMID: 25626036; PMCID: PMC6561347.

  8. Kelly C, Lamont J, Bakken J. Clostridioides (formerly Clostridium) difficile infection in adults: Infección por Clostridium difficile y el papel del trasplante de microbiota fecal Dr. Mario Andrés Chacón Segura, Dra. Laura Vanessa Bermúdez Durán, Dra. Diana Melissa Rojas Sancho e681 Vol. 6(6), junio 2021 - ISSN: 2215-4523 / e-ISSN: 2215-5279 http://revistamedicasinergia.com Treatment and prevention. Uptodate. Wolters Kluwer [internet]. 24 febrero 2021 [citado 10 marzo 2021]; [aprox. 36 p.]. Disponible en: https://www.uptodate.com/contents/clostridioides-formerly-clostridium-difficile-infection-in-adults-treatment-and-prevention

  9. Caliendo A. Lab Interpretation: Positive Clostridioides (formerly Clostridium) difficile in adults. Uptodate. Wolters Kluwer [internet]. 5 mayo 2020 [citado 10 marzo 2021]; [aprox. 6 p.]. Disponible en: https://www.uptodate.com/contents/positive-clostridioides-formerly-clostridium-difficile-in-adults

  10. Bartlett J. Bezlotozumad - A new agent for Clostridium difficile infection. N engl J med [internet]. 2017 [citado 10 marzo 2021]; 376(4): 381-382. https://doi.org/10.1056/NEJMe1614726

  11. Borody T, Ramrakha S. Fecal microbiota transplantation for treatment of Clostridioides (formerly Clostridium) difficile infection. Uptodate. Wolters Kluwer [internet]. 1 febrero 2021 [citado 10 marzo 2021]; [aprox. 20 p.]. Disponible en: https://www.uptodate.com/contents/fecal-microbiota-transplantation-for-treatment-of-clostridioides-formerly-clostridium-difficile-infection

  12. Mullish BH, Quraishi MN, Segal JP, et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018; 67(11): 1920-1941. https://doi.org/10.1136/gutjnl-2018-316818

  13. Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal E, de Vos W, et al. Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile. N engl J med [internet]. 2016 [citado 10 marzo 2021]; 368(5): 407-415. https://doi.org/10.1056/NEJMoa1205037

  14. Kassam Z, Dubois N, Qazi T, Smith M, Kelly C, Fischer M, et al. Donor Screening for Fecal Microbiota Transplantation. N engl J med [internet]. 2019 [citado 10 marzo 2021]; 381(21):[aprox. 3 p.]. https://doi.org/10.1056/NEJMc1913670

  15. Doll M, Marra A, Apisarnthanarak A, Saif Al-Maani A, Abbas S, Rosenthal V. Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious Diseases. Int J Infect Dis [internet]. 2021 [citado 10 marzo 2021]; 102: 188-195. https://doi.org/10.1016/j.ijid.2020.10.039

  16. Clifford L, Kutty P. Clostridioides (formerly Clostridium) difficile infection: Prevention and control.[citado 10 marzo 2021]; [aprox. 19 p.]. Disponible en: https://www.uptodate.com/contents/clostridioides-formerly-clostridium-difficile-infection-prevention-and-control




2020     |     www.medigraphic.com